Nicola Lyttle
University of Edinburgh(GB)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics, Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial(2021)105 cited
- → Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage(2021)47 cited
- → Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer(2018)34 cited
- → Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer(2016)34 cited
- → Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance(2014)27 cited
- → Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial(2013)14 cited
- → A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials(2015)7 cited
- → The TEAM Trial Pathology Study Identifies Potential Prognostic and Predictive Biomarker Models for Postmenopausal Patients Treated with Endocrine Therapy.(2009)5 cited
- → Expression of activated type I receptor tyrosine kinases in early breast cancer(2012)4 cited
- → A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial(2016)2 cited